📍 ORDER WIN

• Hindustan Aeronautics Limited (HAL): The Ministry of Defence has signed a contract worth ₹2,901 crore with HAL for the acquisition of six Advanced Light Helicopters (ALH) Mk-III for the Indian Coast Guard.
• BMW Ventures: The company secured its largest-ever fabricated steel products order worth ₹36 crore for a BHEL project, part of a broader ₹141 crore project opportunity.

📍 SALES UPDATE

• Mahindra & Mahindra (M&M): Total automobile sales in February jumped 18% year-on-year to 97,177 units. Tractor sales saw a massive surge of 34% to 34,133 units, reflecting strong domestic and export demand.
• Adani Ports: The company reported a 16% year-on-year growth in total cargo handled for February 2026, reaching 42.5 million metric tons (MMT), driven by a 14% rise in container volumes.

📍 REGULATORY APPROVAL

• Lupin: The pharmaceutical major received tentative USFDA approval for its Tolvaptan tablets, a generic equivalent of Jynarque. The drug has an estimated annual market size of $287 million in the United States.
• NCC Ltd: The Telangana High Court has suspended a debarment order previously issued against the infrastructure firm by the National Highways Authority of India (NHAI).

📍 INVESTMENT & EXPANSION

• GAIL (India): The board has approved an investment of ₹17.36 billion to set up a new 178.2 MW wind power project in Maharashtra, marking a significant step in the company's green energy transition.
• Reliance Industries (Jio Platforms): Appointed Dan Bailey as President of Jio Platforms to lead the company’s international business initiatives and expansion from London.

📍 OPERATIONAL UPDATE

• JSW Infrastructure: The company reported that one of its storage tanks at the Fujairah Liquid Terminal sustained damage after debris from an intercepted drone fell within the facility; safety protocols were immediately activated.
• Adani Group: Announced a $100 billion commitment to build renewable-powered, AI-ready hyperscale data centers by 2035, aiming to create a $250 billion AI infrastructure ecosystem in India.

📍 PARTNERSHIP

• Emcure Pharmaceuticals: Signed a distribution agreement with Roche to market selected products in the nephrology and transplant care segments in India, effective April 1, 2026.

TAGS: India Daybook, Stocks in News, Corporate News, Stock Market, Company News

Tags: India Daybook Stocks in News Corporate News Stock Market Company News

← Back to All News

View All Articles